Dobaja Borak Mojca, Leonardi Adrijana, Požek Kity, Reberšek Katarina, Podgornik Helena, Pirnat Aljaž, Trampuš Bakija Alenka, Kranjc Brezar Simona, Trobec Tomaž, Žužek Monika C, Frangež Robert, Brvar Miran, Križaj Igor
Centre for Clinical Toxicology and Pharmacology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Doctoral School, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Thromb Haemost. 2025 May;125(5):484-491. doi: 10.1055/a-2408-9375. Epub 2024 Sep 3.
Profound and transient thrombocytopenia of functional platelets without bleeding was observed in patients envenomed by (). This condition was rapidly reversed by administration of F(ab) fragments of immunoglobulin G targeting the whole venom, leaving platelets fully functional. To investigate the potential role of snake venom C-type lectin-like proteins (snaclecs) in this process, -snaclecs were isolated from the crude venom using different liquid chromatographies. The purity of the isolated proteins was confirmed by Edman sequencing and mass spectrometry. The antithrombotic effect was investigated by platelet agglutination and aggregation assays and blood coagulation tests. Using flow cytometry, the platelet activation and binding of -snaclecs to various platelet receptors was analyzed. Antithrombotic efficacy was tested in vivo using a mouse model of vascular injury. Two -snaclecs were purified from the venom. One of them, -snaclec-3/2, inhibited ristocetin-induced platelet agglutination. It is a covalent heterodimer of -snaclec-3 (α-subunit) and -snaclec-2 (β-subunit). Our results suggest that -snaclec-3/2 induces platelet agglutination and consequently thrombocytopenia by binding to the platelet receptor glycoprotein Ib. Essentially, no platelet activation was observed in this process. In vivo, -snaclec-3/2 was able to protect the mouse from ferric chloride-induced carotid artery thrombosis, revealing its applicative potential in interventional angiology and cardiology.
被()毒液咬伤的患者出现了功能性血小板严重且短暂的血小板减少,但无出血现象。通过给予靶向全毒液的免疫球蛋白G的F(ab)片段,这种情况迅速得到逆转,血小板功能完全恢复正常。为了研究蛇毒C型凝集素样蛋白(snaclecs)在此过程中的潜在作用,使用不同的液相色谱法从粗毒液中分离出了-snaclecs。通过埃德曼测序和质谱法确认了分离蛋白的纯度。通过血小板凝集和聚集试验以及凝血试验研究了抗血栓形成作用。使用流式细胞术分析了-snaclecs对各种血小板受体的血小板活化和结合情况。在血管损伤小鼠模型中对体内抗血栓形成功效进行了测试。从毒液中纯化出了两种-snaclecs。其中一种,-snaclec-3/2,抑制了瑞斯托霉素诱导的血小板凝集。它是-snaclec-3(α亚基)和-snaclec-2(β亚基)的共价异二聚体。我们的结果表明,-snaclec-3/2通过与血小板受体糖蛋白Ib结合诱导血小板凝集,进而导致血小板减少。从本质上讲,在此过程中未观察到血小板活化。在体内,-snaclec-3/2能够保护小鼠免受氯化铁诱导的颈动脉血栓形成,揭示了其在介入血管学和心脏病学中的应用潜力。